Form DEF 14A REGENERON PHARMACEUTICAL For: Jun 12
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260424/ATZ2I22C3222N2Z222222WZZ6G8O92UI5282
Filed on: April 24, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
- Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
- Striding AI Announces Development of Next-Generation Robotic Foundation Systems for Physical AI Deployment
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
